KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biocryst Pharmaceuticals (BCRX) Return on Invested Capital (2024 - 2025)

Biocryst Pharmaceuticals' Return on Invested Capital history spans 2 years, with the latest figure at 1.34% for Q4 2025.

  • For Q4 2025, Return on Invested Capital fell 135.0% year-over-year to 1.34%; the TTM value through Dec 2025 reached 1.34%, down 135.0%, while the annual FY2025 figure was 1.14%, 115.0% down from the prior year.
  • Return on Invested Capital reached 1.34% in Q4 2025 per BCRX's latest filing, down from 0.25% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.01% in Q4 2024 to a low of 1.34% in Q4 2025.